Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers

DNA Repair

Volumn 8, Issue 1, 2009, Pages 60-71

  Neasham, David ^a   Gallo, Valentina ^a   Guarrera, Simonetta ^b   Dunning, Alison ^c   Overvad, Kim ^d   Tjonneland, Anne ^e   Clavel Chapelon, Francoise ^f   Linseisen, Jakob P ^g   Malaveille, Christian ^h   Ferrari, Pietro ^h   Boeing, Heiner ⁱ   Benetou, Vassiliki ^j   Trichopoulou, Antonia ^j   Palli, Domenico ^k   Crosignani, Paolo ^l   Tumino, Rosario ^m   Panico, Salvatore ⁿ   Bueno De Mesquita, H Bas ^o   Peeters, Petra H ^p   van Gib, Carla H ^p   Lund, Eiliv ^q   Gonzalez, Carlos A ^r   Martinez, Carmen ^s   Dorronsoro, Miren ^t   Barricarte, Aurelio ^u   Navarro, Carmen ^v   Quiros, Josè R ^w   Berglund, Goran ^x   Jarvholm, Bengt ^y   Khaw, Kay Tee ^c   Key, Timothy J ^z   Bingham, Sheila ^aa   Diaz, Tormo M Jose ^v   Riboli, Elio ^a   Matullo, Giuseppe ^b   Vineis, Paolo ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ISI FOUNDATION   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f INSERM   (France)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m CIVILE M P AREZZO HOSPITAL   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q UNIVERSITY OF TROMSØ   (Norway)

^r CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t Department of Public Health of Guipuzkoa ^*  (Spain)

^u INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^v DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^w Direccion General de Salud Publica   (Spain)

^x LUND UNIVERSITY   (Sweden)

^y UMEÅ UNIVERSITY   (Sweden)

^z UNIVERSITY OF OXFORD   (United Kingdom)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Cancer; DNA repair; Mortality; Prospective study

Indexed keywords

ADULT; AGED; ALLELISM; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; COHORT ANALYSIS; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

COHORT STUDIES; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MORTALITY; NEOPLASMS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 56749154388     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2008.08.012     Document Type: Article

References (40)

1. Olaussen K.A., et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N. Engl. J. Med. 355 (2006) 983-991
2. Li D., Liu H., Jiao L., Chang D.Z., Beinart G., Wolff R.A., Evans D.B., Hassan M.M., and Abbruzzese J.L. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res. 66 (2006) 3323-3330
3. Bosken C.H., Wei Q., Amos C.I., et al. An analysis of DNA repair as a determinant of survival in patients with non-small cell lung cancer. J. Natl. Cancer 94 (2002) 1091-1099
4. Camps C., Sarries C., Roig B., et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin. Lung Cancer 4 (2003) 237-241
5. Bewick M.A., Conlon S.C., and Lafrenie R.M. Polymorphisms in XRCC1 XRCC3 and CCND1 and survival after treatment for metastatic breast cancer. J. Clin. Oncol. 24 (2006) 5645-5651
6. Gal T.J., Huang W.Y., Chen C., Hayes R.B., and Schwartz S.M. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 115 (2005) 2221-2231
7. Vispe S., Yung T.M., Ritchot J., Serizawa H., and Satoh M.S. A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9886-9891
8. Knudson A. The genetic predisposition to cancer. Birth Defects Orig. Artic. Ser. 25 (1989) 15-27
9. Squire J.A., Whitmore G.F., and Phillips R.A. Genetic basis of cancer. In: Tannock I.F., Tannock I., and Hill R.P. (Eds). The Basic Science of Oncology. 3rd ed. (1998), McGraw-Hill Press
10. Friedberg E.C. In: Friedberg E.C., Walker G.C., and Siede W. (Eds). DNA Repair and Mutagenesis (1995), ASM Press, Washington, DC
11. Vineis P., Hoek G., Krzyzanowski M., Vigna-Taglianti F., Veglia F., Airoldi L., Autrup H., Dunning A., Garte S., Hainaut P., Malaveille C., Matullo G., Overvad K., Raaschou-Nielsen O., Clavel-Chapelon F., Linseisen J., Boeing H., Trichopoulou A., Palli D., Peluso M., Krogh V., Tumino R., Panico S., Bueno-De-Mesquita H.B., Peeters P.H., Lund E.E., Gonzalez C.A., Martinez C., Dorronsoro M., Barricarte A., Cirera L., Quiros J.R., Berglund G., Forsberg B., Day N.E., Key T.J., Saracci R., Kaaks R., and Riboli E. Air pollution and risk of lung cancer in a prospective study in Europe. Int. J. Cancer 119 (2006) 169-174
12. Peluso M., et al. Methodology of laboratory measurements in prospective studies on gene-environment interactions: the experience of GenAir. Mutat. Res. 574 (2005) 92-104
13. Wacholder S., Channock S., Garcia-Closas M., El Ghormli L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96 (2004) 434-442
14. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker D.J., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., and Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell 1 (1998) 783-793
15. Wiese C., Collins D.W., Albala J.S., Thompson L.H., Kronenberg A., and Schild D. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. Nucleic Acids Res. 30 (2002) 1001-1008
16. Johnson R.D., Liu N., and Jasin M. Mammalian XRCC2 promotes the repair of DNA double strand breaks by homologous recombination. Nature 401 (1999) 397-399
17. Pierce A.J., Johnson R.D., Thompson L.H., and Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13 (1999) 2633-2638
18. Tsaryk R., Fabian K., Thacker J., and Kaina B. XRCC2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide. Cancer Lett. 239 (2006) 305-313
19. Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum-based anti-cancer chemotherapy. Cancer Treat. Rev. 24 (1998) 331-344
20. Gerson S.L., Berger N.A., Arce C., Petzold S.J., and Willson J.K. Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine. Biochem. Pharmacol. 43 (1992) 1101-1107
21. Jiricny J. Eukaryotic mismatch repair: an update. Mutat. Res. 409 (1998) 107-121
22. B. Lewin, Genes VIII, Pearson Prentice Hall, Upper Saddle River, NJ, USA (2004).
23. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.-C., Blasco M.A., and Serrano M. "Super P53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21 (2002) 6225-6235
24. Efeyan A., Garcia-Cao I., Herranz D., Velasco-Miguel S., and Serrano M. Tumour biology: policing of oncogene activity by p53. Nature 443 (2006) 159
25. Kronenwett U., Ploner A., Zetterberg A., Bergh J., Hall P., Auer G., and Pawitan Y. Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1630-1635
26. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1513-1530 (Review)
27. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M., and Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1614-1618
28. Wei Q., Cheng L., Hong W.K., and Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 56 (1996) 4103-4107
29. Chen W.D., Eshelman J.R., Aminoshariae M.R., Ma A.H., Veoloso N., Markowitz S.D., et al. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells. J. Natl. Cancer Inst. 92 (2000) 480-485
30. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., and Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22 (2001) 1437-1445
31. Au W.W., Salama S.A., and Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 111 (2003) 1843-1850
32. Kiuru A., Lindholm C., Heilimo I., Ceppi M., Koivistoinen A., Ilus T., Hirvonen A., Norppa H., and Salomaa S. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ Mol. Mutagen. 46 (2005) 198-205
33. Mahmoudi M., Mercer J., and Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 71 (2006) 259-268
34. Randerath E., Miller R.H., Mittal D., Avitts T.A., Dunsford H.A., and Randerath K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. J. Natl. Cancer Inst. 81 (1989) 341-347
35. Lewtas J., Mumford J., Everson R.B., Hulka B., Wilcosky T., Kozumbo W., Thompson C., George M., Dobias L., Sram R., Li X., and Gallagher J. Comparison of DNA adducts from complex mixture exposures in various human tissues and experimental systems. Environ Health Perspect. 99 (1993) 88-97
36. Randerath E., Avitts T.A., Reddy M.V., Miller R.H., Everson R.B., and Randerath K. Comparative 32P-analysis of cigarette smoke induced DNA damage in human tissues and mouse skin. Cancer Res. 46 (1986) 5869-5877
37. Izzotti A., Balansky R.M., D'Agostini F., Bennicelli C., Myers S.R., Grubbs C.J., Lubet R.A., Kelloff G.J., and De Flora S. Modulation of biomarkers by chemo-preventive agents in smoke exposed rats. Cancer Res. 61 (2001) 2472-2479
38. Binkova B., Smerhovsky Z., Strejc P., Boubelik O., Stavkova Z., Chvatalova I., et al. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat. Res. 501 (2002) 115-128
39. Botto N., Masetti S., Petrozzi L., Vassalle C., Manfredi S., Biagini A., et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron. Artery Dis. 13 (2002) 269-274
40. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., and Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932